EDGAR Filing Documents for 0000919574-13-005739

Form SC 13G - Statement of Beneficial Ownership by Certain Investors:

SEC Accession No. 0000919574-13-005739

Filing Date

2013-10-04

Accepted

2013-10-04 12:47:25

Documents

Document Format Files

Seq	Description	Document	Type	Size
1		d1418968_13-g.htm	SC 13G	187245
	Complete submission text file	0000919574-13-005739.txt		188813

Mailing Address 237 PARK AVENUE, 9TH FLOOR NEW YORK NY 10017

Business Address 237 PARK AVENUE, 9TH FLOOR NEW YORK NY 10017 212-808-2463

Broadfin Capital, LLC (Filed by) CIK: 0001511901 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address C/O MARK COHEN, CHAIRMAN, PEARL COHEN 1500 BROADWAY, 12TH FLOOR NEW YORK NY 10036

Business Address 53 DAVIES STREET LONDON X0 W1K 5JH 646-878-0804

Celsus Therapeutics Plc. (Subject) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: SC 13G | Act: 34 | File No.: 005-87614 | Film No.: 131136061
SIC: 2834 Pharmaceutical Preparations